Jim Cramer says investors should buy these 11 recently-boosted dividend stocks

Jim Cramer says investors should buy these 11 recently-boosted dividend stocks


CNBC’s Jim Cramer on Thursday offered investors a list of dividend stocks with yields that recently increased, that he believes buyers should add to their portfolio.

Dividends are a generally “unassailable defense against a volatile market,” the “Mad Money” host said, which means that they can be attractive additions to the portfolio of an investor worried about Russia’s invasion of Ukraine, soaring inflation and Covid fears that have roiled the market in recent weeks.

“You want bountiful dividends that are also safe, and the best way to determine a dividend’s safety is by searching for the companies that have recently raised their payouts, because that’s the ultimate sign of confidence in the future,” Cramer said. “Plus, with interest rates on the rise, only the dividend boosters can keep up with the bond market competition,” he added.

To come up with his list, which he said are the “biggest dividend raisers of 2022 so far,” Cramer only included stocks which raised dividends this year by more than 20%. Using this criteria, he shrunk the list of hundreds of stocks listed in the S&P 500 to 27 names, then down to 11 stocks that he believes can outpace inflation and be attractive additions to buyer’s portfolios.

Here is the list:

  1. Pioneer Natural Resources
  2. Coterra Energy
  3. Devon Energy
  4. Halliburton
  5. Tractor Supply
  6. Best Buy
  7. Dollar General
  8. NXP Semiconductors
  9. Prologis
  10. Wells Fargo
  11. American Express

“When the Fed is tightening to combat rampant inflation, I don’t want you to overthink it — you want to circle the wagons around companies that are rapidly raising their dividends,” Cramer said.

Disclosure: Cramer’s Charitable Trust owns shares of Devon, Halliburton and Wells Fargo.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

E.l.f. Beauty posts earnings beat, raises full-year guidance
Business

E.l.f. Beauty posts earnings beat, raises full-year guidance

Elf Beauty cosmetics Courtesy: e.l.f Beauty E.l.f. Beauty reported a huge earnings beat Wednesday and raised its guidance for the fiscal year. E.l.f. stock was up as much as 15% in after-hours trading before losing the majority of those gains. Here’s what the company reported for the third fiscal quarter, compared with analyst estimates from […]

Read More
Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs
Business

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable. “It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of […]

Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Business

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market.  Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]

Read More